Babool
Vachellia nilotica
Babool (Vachellia nilotica) is a thorny tree widely utilized in Ayurveda. Its bark, gum, and pods are commonly used. In traditional practices, it's claimed to balance Kapha and Pitta doshas. Prevalent across India, it's often used for its supposed astringent and healing properties, highlighting its significance in traditional medicine.
PLANT FAMILY
Fabaceae (Legume)
PARTS USED
Bark, Gum, Pods
AYURVEDIC ACTION
Kapha ↓, Pitta ↓
ACTIVE COMPOUNDS
Tannins (12-18%)
What is Babool?
Babool, scientifically known as Vachellia nilotica, is a thorny tree native to Africa, the Middle East, and the Indian subcontinent. It belongs to the Fabaceae (Legume) family, characterized by its distinctive pods and bipinnate leaves. The tree produces a strong, durable wood and a valuable gum, and its bark, gum, and pods are traditionally used in various applications.
Known for its resilience and adaptability, Babool thrives in arid and semi-arid regions. Its extensive root system helps in soil stabilization, and its ability to fix nitrogen contributes to soil fertility. Beyond its ecological role, the tree holds cultural and economic significance in many communities.
Other Names of Babool
- Babul
- Indian Gum Arabic Tree
- Egyptian Thorn
- Prickly Acacia
- Kikar

Heading
<h3> Absolute Contraindications of Babool (Acacia nilotica) </h3> <h4> Known Allergy / Sensitivity to Acacia or Gum Arabic (tree-derived gums) [If you have a plant/latex or gum allergy]</h4> <ul> <li>🛑</li> <li>Recommendation: Do not use any Babool preparations (oral, topical or ingested) if you have a known allergy to acacia/gum-based products; avoid exposure and consult an allergist before any trial.</li> <li>Reasoning: Acacia-derived gums are documented sensitizers in occupational and consumer exposures; inhaled or topical exposure can cause rhinitis, asthma, urticaria or contact dermatitis in sensitized individuals.</li> <li>Scientific_Study_Title: Gum arabic as a cause of occupational allergy.</li> <li>Scientific_Study_Authors: Andersson, M., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21747872/</li> <li>Scientific_Study_Excerpt: <p>The cited occupational series described workers exposed to gum arabic who developed respiratory and skin symptoms. Objective testing (skin tests, pulmonary function, provocation) confirmed occupational asthma and contact urticaria attributable to gum arabic exposure in several cases. One patient also reported oral symptoms after ingestion of gum-containing products. The report highlights that airborne or mucosal exposure can sensitize and provoke allergic disease in susceptible individuals, and that avoidance of the acacia-derived gum was required for symptomatic control.</p> </li> </ul> <h4> Pre-existing Significant Liver Disease or Concurrent Use of Hepatotoxic Drugs [If you have hepatitis, cirrhosis or take drugs that stress the liver]</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid regular or high-dose use of Babool extracts if you have active liver disease or are on hepatotoxic medications; discuss with your hepatologist before any trial.</li> <li>Reasoning: Repeated high doses of some A. nilotica extracts in animal studies produced elevations in liver enzymes and other biochemical changes suggesting potential for hepatic stress at higher/sub-chronic doses.</li> <li>Scientific_Study_Title: Toxicological studies of aqueous extract of Acacia nilotica root.</li> <li>Scientific_Study_Authors: Adesokan AA, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27486360/</li> <li>Scientific_Study_Excerpt: <p>In sub-acute studies in rats, oral administration of aqueous root extract at repeated higher doses (≥250 mg/kg body weight) for 28 days produced statistically significant increases in serum markers of hepatic enzyme activity (ALT, AST, ALP) at the top dose, suggesting liver stress. While single-dose (acute) exposure was not lethal, the authors concluded that repeated administration of higher doses may be associated with hepatotoxic changes and should be used cautiously.</p> </li> </ul> <h4> Male Fertility Concerns / Trying to Conceive (Men) [If you are trying for biological children]</h4> <ul> <li>👶❌</li> <li>Recommendation: Men trying to conceive should avoid regular Babool supplementation until further human safety data are available.</li> <li>Reasoning: Long-term administration in male rats caused reductions in sperm motility, progressive motility and sperm counts, raising concern about potential effects on male fertility.</li> <li>Scientific_Study_Title: The Anti-fertility Effects of Acacia nilotica in Male Wistar Rats.</li> <li>Scientific_Study_Authors: Ramesh, R., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23926560/</li> <li>Scientific_Study_Excerpt: <p>In a controlled rat study, males treated with A. nilotica showed statistically significant decreases in sperm motility, progressive motility and sperm concentration compared with controls after prolonged exposure. Histological examination revealed testicular changes, and some effects were reversible after withdrawal but the study authors warned of potential reproductive implications with chronic use in males.</p> </li> </ul> <h3> Relative Contraindications of Babool (Acacia nilotica) </h3> <h4> Concurrent Use of Antidiabetic Medications / Risk of Hypoglycaemia [If you are on insulin or oral hypoglycaemics]</h4> <ul> <li>🔽</li> <li>Recommendation: Use only under medical supervision with close glucose monitoring; doses of antidiabetic drugs may need adjustment.</li> <li>Reasoning: Animal studies show hypoglycaemic and enzyme-inhibitory activity (α-amylase/α-glucosidase inhibition) and blood-glucose lowering effects; combined use with medications that lower glucose could cause additive hypoglycaemia.</li> <li>Scientific_Study_Title: Duration effect of Acacia nilotica leaves extract and glibenclamide as hypolipidaemic and hypoglycaemic activity in alloxan induced diabetic rats.</li> <li>Scientific_Study_Authors: Ezeja, M. I., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26627505/</li> <li>Scientific_Study_Excerpt: <p>In alloxan-induced diabetic rats, aqueous leaf extracts of A. nilotica produced significant decreases in fasting blood glucose and improved lipid profiles, effects comparable in direction (though not identical in magnitude) to glibenclamide. The extract inhibited carbohydrate-digesting enzymes in vitro and lowered glucose in vivo, indicating potential for additive hypoglycaemic interactions when combined with antidiabetic drugs.</p> </li> </ul> <h4> Concurrent Use of Antiplatelet or Anticoagulant Medications [If you take aspirin, clopidogrel, warfarin, DOACs]</h4> <ul> <li>🩸</li> <li>Recommendation: Discuss with your prescribing clinician; consider closer monitoring of coagulation/platelet function if a clinician advises combined use, or avoid if risk is high.</li> <li>Reasoning: Experimental data show reduced platelet aggregation in diabetic rat models after A. nilotica extract - this suggests potential additive antiplatelet effects when combined with blood-thinning drugs.</li> <li>Scientific_Study_Title: Effect of Acacia nilotica leaves extract on hyperglycaemia, lipid profile and platelet aggregation in streptozotocin induced diabetic rats.</li> <li>Scientific_Study_Authors: Al-Furqan, K., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24800330/</li> <li>Scientific_Study_Excerpt: <p>In streptozotocin-diabetic rats, treatment with A. nilotica extract reduced platelet aggregation and altered beta-thromboglobulin levels compared with diabetic controls. Although the mechanism is not fully defined, the finding supports a platelet-modulating effect that could interact with antiplatelet/anticoagulant therapy in humans.</p> </li> </ul> <h4> Pregnancy & Breastfeeding (Precautionary) [If pregnant or nursing]</h4> <ul> <li>🤰⚠️</li> <li>Recommendation: Avoid routine use during pregnancy and breastfeeding due to lack of robust human safety data and animal signals about reproductive effects; discuss with your OB clinician if considering use.</li> <li>Reasoning: Direct human pregnancy safety data are lacking; animal studies showing reproductive effects and limited toxicity signals justify a precautionary approach.</li> <li>Scientific_Study_Title: The Anti-fertility Effects of Acacia nilotica in Male Wistar Rats.</li> <li>Scientific_Study_Authors: Ramesh, R., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23926560/</li> <li>Scientific_Study_Excerpt: <p>Although the cited work studied males, the demonstration of reproductive organ and sperm changes with chronic exposure in animals is one reason clinicians commonly recommend avoiding new herbal agents during pregnancy and lactation until human safety is proven. The evidence supports cautionary avoidance in pregnancy and breastfeeding settings.</p> </li> </ul>
Heading
<h4> Liver enzyme elevation / potential hepatotoxicity</h4> <ul> <li>🧪</li> <li>Side effect summary: Repeated high-dose use of certain A. nilotica extracts in animals was associated with elevated liver enzymes, suggesting possible liver stress with chronic high dosing.</li> <li>Recommendation: Stop use and see a doctor if you develop jaundice, persistent abdominal pain, dark urine, or unexplained fatigue; avoid if you have known liver disease.</li> <li>Reasoning: Sub-acute rodent experiments showed dose-related increases in ALT, AST and ALP at higher repeated doses, indicating hepatic cell stress or injury risk with prolonged high intake.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Toxicological studies of aqueous extract of Acacia nilotica root.</li> <li>Scientific_Study_Authors: Adesokan AA, Akanji MA.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27486360/</li> <li>Scientific_Study_Excerpt: <p>The sub-acute toxicity evaluation in rats showed that while acute single-dose exposure was non-lethal, repeated oral doses (250-500 mg/kg) for 28 days produced statistically significant increases in hepatic enzyme activities (ALT, AST, ALP) especially at the highest dose, consistent with hepatic stress. The authors concluded that prolonged high-dose consumption could be associated with hepatotoxicity risk in experimental models.</p> </li> </ul> <h4> Allergic reactions (skin rashes, contact dermatitis, respiratory symptoms)</h4> <ul> <li>🌿</li> <li>Side effect summary: Topical or inhalational exposure to acacia-derived gums can trigger contact dermatitis, urticaria, or occupational asthma in sensitized individuals.</li> <li>Recommendation: Discontinue use immediately if rash, hives, wheeze or breathing difficulty occurs; seek medical care for systemic reactions.</li> <li>Reasoning: Case series and occupational studies demonstrate that acacia gums can sensitize and produce both skin and respiratory allergic disease.</li> <li>Severity Level: Mild-Moderate (can be Severe in anaphylaxis - seek urgent care)</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Gum arabic as a cause of occupational allergy.</li> <li>Scientific_Study_Authors: Andersson M., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21747872/</li> <li>Scientific_Study_Excerpt: <p>Investigation of candy-factory workers exposed to gum arabic documented cases of occupational asthma, contact urticaria and rhinitis attributable to gum arabic sensitization, confirmed by skin testing and provocation. The report highlights that acacia-derived gums are not universally benign and can cause clinically significant allergic disease in exposed workers and consumers.</p> </li> </ul> <h4> Gastrointestinal upset & weight changes</h4> <ul> <li>🤢</li> <li>Side effect summary: High or chronic doses in animal feeding studies were associated with decreased body weight and changes in some blood parameters; transient GI symptoms are possible in humans.</li> <li>Recommendation: Start with low amounts if using orally and stop if you develop persistent nausea, vomiting or unexplained weight loss; consult a clinician if severe.</li> <li>Reasoning: Rodent feeding studies reported reduced body weight and changes in hemoglobin and serum protein at higher dietary concentrations, although effects reversed after stopping treatment.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: A study on the toxicology of Acacia nilotica.</li> <li>Scientific_Study_Authors: Adesokan AA, Akanji MA.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10794124/</li> <li>Scientific_Study_Excerpt: <p>In rats fed diets containing 2% and 8% acacia for 2-4 weeks, researchers observed significant reductions in body weight and decreases in hemoglobin, serum total protein and total cholesterol in the higher-dose groups; these changes reversed after stopping the acacia diet. No deaths or major histopathological liver changes were seen, and the authors judged low acute toxicity but noted physiological effects at dietary exposure levels.</p> </li> </ul>
Heading
<h4> Antidiabetic drugs (insulin, sulfonylureas, metformin, etc.)</h4> <ul> <li>Interaction_Details: Acacia extracts lower blood glucose via enzyme inhibition and metabolic effects; taken with antidiabetic drugs they may increase the risk of low blood sugar (additive effect).</li> <li>Severity: Moderate</li> <li>Recommendation: Monitor blood glucose closely; consult your prescriber-dose adjustment of antidiabetic medication may be needed or avoid combined use without supervision.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26627505/</li> <li>Scientific_Study_Title: Duration effect of Acacia nilotica leaves extract and glibenclamide as hypolipidaemic and hypoglycaemic activity in alloxan induced diabetic rats.</li> <li>Scientfic_Study_Authors: Ezeja MI, et al.</li> <li>Scientific_Study_Excerpt: <p>Alloxan-induced diabetic rats given A. nilotica leaf extract showed significant reductions in fasting blood glucose and improvements in lipid profile. The extract’s glucose-lowering effects produced outcomes directionally similar to glibenclamide in the model, supporting the potential for additive hypoglycaemic interactions when combined with antidiabetic medicines in clinical settings.</p> </li> </ul> <h4> Antiplatelet / Anticoagulant agents (aspirin, clopidogrel, warfarin, DOACs)</h4> <ul> <li>Interaction_Details: Experimental data show reduced platelet aggregation after A. nilotica extract; combined use with blood-thinning drugs could increase bleeding risk.</li> <li>Severity: Moderate</li> <li>Recommendation: Avoid unsupervised combination; if clinically necessary, consult prescriber and monitor bleeding parameters/INR (for warfarin) or clinical signs of bleeding.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24800330/</li> <li>Scientific_Study_Title: Effect of Acacia nilotica leaves extract on hyperglycaemia, lipid profile and platelet aggregation in streptozotocin induced diabetic rats.</li> <li>Scientfic_Study_Authors: Al-Furqan K., et al.</li> <li>Scientific_Study_Excerpt: <p>In streptozotocin diabetic rats, oral administration of A. nilotica extract reduced platelet aggregation and altered markers related to platelet activation compared with diabetic controls. These findings support a platelet-modulating activity that could theoretically potentiate the effect of antiplatelet/anticoagulant drugs and increase bleeding risk.</p> </li> </ul> <h4> Hepatotoxic drugs (e.g., high-dose acetaminophen, certain antifungals, some antitubercular drugs)</h4> <ul> <li>Interaction_Details: Because repeated high doses of Babool extracts produced hepatic enzyme elevations in animals, co-administration with other hepatotoxic drugs could raise the risk of liver injury.</li> <li>Severity: Moderate</li> <li>Recommendation: Avoid combining with known hepatotoxins where possible; if unavoidable, obtain baseline liver tests and monitor periodically under clinician guidance.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27486360/</li> <li>Scientific_Study_Title: Toxicological studies of aqueous extract of Acacia nilotica root.</li> <li>Scientfic_Study_Authors: Adesokan AA, Akanji MA.</li> <li>Scientific_Study_Excerpt: <p>Sub-acute dosing of aqueous A. nilotica root extract in rats at higher doses led to significant increases in hepatic enzyme activities (ALT, AST, ALP) suggesting hepatic stress. The study cautioned that repeated high doses may be hepatotoxic in experimental settings, implying that concomitant hepatotoxic medicines may increase overall liver risk.</p> </li> </ul>